Two biotech majors, Innovassynth and TCG Life Sciences (TCGLS) have started operations from Pune’s TCG International Biotech Park (TCGIBP) which is India’s first integrated biotech park and the largest biotechnology facility in Western India.

Talking about the move, Dr Hardik Joshipura, MD and CEO, Innovassynth said, “We are into custom development and manufacturing of nucleosides and specialty chemicals for clients across the globe. We have an existing manufacturing facility at Khopoli and wanted to consolidate our operations with a state-of-the-art R&D facility in an integrated biotechnology park. With this we plan to further strengthen our Contract Research (CRO) capabilities. TCG International Biotech Park became our first choice as it is India’s first integrated biotechnology park and is the largest such facility in Western India. We wanted to benefit from the conducive ecosystem for innovation, research and development existing in Pune currently.”

TCGLS, a group company of The Chatterjee Group (TCG) and a global contract research organisation (CRO) and contract development and manufacturing organisation (CDMO) company with operations in Kolkata, Hyderabad, Richmond, Virginia, and Princeton, New Jersey; offering seamless and integrated R&D services to pharma, biotech, agriscience, animal health, specialty chemicals, and related industries have started operations from TCG IBP in Pune as part of their expansion plans. "We've taken up 23,000 square feet space in TCGIBP to build a comprehensive discovery services centre. Pune with its proximity to Mumbai and Gujarat offers a great ecosystem of talents, scientific institutions, and relevant industry players which TCGLS plans to leverage to build a major presence by bringing in a sizeable batch of chemists, biologists, and formulation scientists in the coming years,” said Anirban Mitra, Head of Human Resource Development at TCGLS.